M. Karina

发表

Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.

U. Dafni, G. Aravantinos, G. Fountzilas, 2009, Anticancer research.

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.

C. Papadimitriou, T. Economopoulos, H. Kalofonos, 2008, European journal of cancer.

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck

N. Pavlidis, T. Economopoulos, G. Fountzilas, 2005, Medical oncology.

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

U. Dafni, H. Gogas, C. Markopoulos, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study

N. Pavlidis, G. Fountzilas, V. Golfinopoulos, 2010, Anti-cancer drugs.

Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.

M. Ignatiadis, P. Selviaridis, G. Fountzilas, 2006, Anticancer research.

Three Case Reports of Hand-Foot Syndrome with Gefitinib

G. Fountzilas, E. Razis, M. Karina, 2006, Cancer investigation.

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2005, Anticancer research.

Effect of the UK postcode lottery on survival of patients with metastatic renal cancer: an audit of outcomes in patients with metastatic renal cancer suitable for treatment with tyrosine kinase inhibitors.

E. Porfiri, S. Collins, J. Pascoe, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

G. Fountzilas, G. Pentheroudakis, V. Karavasilis, 2009, BMC Cancer.

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

M. Dimopoulos, U. Dafni, H. Gogas, 2012, Breast Cancer Research and Treatment.

Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.

G. Fountzilas, D. Pectasides, S. Murray, 2007, Anticancer research.

A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancer.

G. Fountzilas, I. Skiadas, M. Karina, 2005, Anticancer research.

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

M. Dimopoulos, U. Dafni, H. Gogas, 2009, Breast Cancer Research and Treatment.

Paclitaxel and Gemcitabine, As First-Line Chemotherapy, Combined with Trastuzumab in Patients with Advanced Breast Cancer: A Phase II Study Conducted by the Hellenic Cooperative Oncology Group (HeCOG)

H. Gogas, G. Fountzilas, D. Skarlos, 2004, Cancer investigation.

Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.

H. Gogas, G. Fountzilas, D. Skarlos, 2003, Clinical breast cancer.

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

G. Fountzilas, M. Dimopoulos, G. Fountzilas, 2010, Cancer Chemotherapy and Pharmacology.

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.

U. Dafni, T. Economopoulos, K. Syrigos, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.

G. Fountzilas, A. Goussia, D. Skarlos, 2007, Anticancer research.

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2011, BMC medicine.

Gemcitabine (G) vs gemcitabine-carboplatin (GCB) for patients with advanced non-small cell lung cancer (NSCLC) and PS:2. A prospective randomized phase II study of the Hellenic Co-Operative Oncology Group

I. Boukovinas, H. Kalofonos, D. Pectasides, 2004 .

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.

M. Dimopoulos, T. Economopoulos, H. Kalofonos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II study

T. Economopoulos, G. Pentheroudakis, A. Bamias, 2008, Acta oncologica.

Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study

N. Pavlidis, G. Fountzilas, V. Golfinopoulos, 2010, Anti-cancer drugs.